RRC ID |
63888
|
Author |
Ishizuka T, Nagata W, Nomura-Takahashi S, Satoh Y.
|
Title |
Effects of oxidized low-density lipoprotein on differentiation of mouse neural progenitor cells into neural cells.
|
Journal |
Eur J Pharmacol
|
Abstract |
In Alzheimer's disease (AD), a decline in function of neural progenitor cells (NPCs) results in a reduced capacity for neural regeneration. It has been shown that plasma oxidized low-density lipoprotein (ox-LDL) levels are positively correlated with severity in patients with AD. However, the direct effects of ox-LDL on NPCs are unknown. Thus, we examined the effects of ox-LDL on the proliferation and differentiation of mouse NPCs into neural cells. Mouse induced pluripotent stem (iPS) cell-derived embryoid bodies were stimulated with Noggin and SB431542 for 4 days. Mouse NPCs were then collected using anti-polysialic acid-neural cell adhesion molecule antibodies in a magnetic separator. The proliferation of mouse NPCs was examined using the MTT assay. The differentiation of mouse NPCs into neural cells was examined by the expression of NeuN (a neuronal-specific nuclear protein) using immunofluorescence staining and Western blot analysis. Treatment with ox-LDL did not affect the proliferation of mouse NPCs. While treatment with all-trans retinoic acid (ATRA), epidermal growth factor (EGF), and basic fibroblast growth factor (FGF) significantly induced NeuN expression in the differentiated NPCs (P < 0.01), the addition of ox-LDL significantly inhibited the NeuN expression (P < 0.05). Pretreatment with SC-79 (an Akt activator) significantly reversed the inhibitory effect of ox-LDL on NeuN expression (P < 0.05). Treatment with ox-LDL significantly inhibited Akt phosphorylation (P < 0.05) and CREB phosphorylation induced by ATRA, EGF, and basic FGF (P < 0.05). The present study indicates that treatment with ox-LDL inhibits the differentiation of mouse NPCs into neural cells by inhibiting Akt and CREB activation.
|
Volume |
888
|
Pages |
173456
|
Published |
2020-12-5
|
DOI |
10.1016/j.ejphar.2020.173456
|
PII |
S0014-2999(20)30548-3
|
PMID |
32771670
|
MeSH |
Animals
Cell Differentiation / drug effects
Cell Differentiation / physiology*
Cells, Cultured
Dose-Response Relationship, Drug
Induced Pluripotent Stem Cells / drug effects
Induced Pluripotent Stem Cells / physiology
Lipoproteins, LDL / pharmacology*
Mice
Neural Stem Cells / drug effects
Neural Stem Cells / physiology*
Neurons / drug effects
Neurons / physiology*
Proto-Oncogene Proteins c-akt / antagonists & inhibitors
Proto-Oncogene Proteins c-akt / physiology
|
IF |
3.263
|
Resource |
Human and Animal Cells |
iPS-MEF-Ng-20D-17(APS0001) |